More than 30,000 patients with Type 1 diabetes across the UK Midlands now have access to life-changing continuous glucose monitoring technology, thanks to cost-effective deals secured for patients and rapidly rolled out by the NHS.
In the summer of 2022, the NHS announced patients with Type 1 diabetes would be eligible for continuous glucose monitors (CGMs) after securing a deal to ensure they cost a similar price to flash glucose monitors have been available on the NHS for the past few years and need the patient to ‘scan’ the device to get a reading. However, CGM devices do not need the patient to ‘scan’, and instead send glucose readings continuously to a smartphone app. In line with NICE guidance, patients will be offered either monitor depending on their needs following consultation with their local clinician.
The latest rollout figures show the NHS in England is going well above and beyond its original Long Term Plan target from 2019 to ensure 20% of people with Type 1 diabetes would benefit from flash or continuous glucose monitors, with over 70% of people with Type 1 diabetes now using these systems.
To read more CLICK HERE.
